Can-Fite BioPharma (CANF) Stock Chart & Stock Price History $0.68 -0.01 (-1.65%) As of 10:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Can-Fite BioPharma Stock Price Performance The Can-Fite BioPharma (CANF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 73.29%, with a year-to-date return of -57.85%. In the past month, the stock has decreased 33.82%, reflecting recent market activity. As of the latest close, Can-Fite BioPharma traded at $0.70 with a market cap of $2.47 million and volume of 248,829 shares. Five years ago, the stock traded at a split-adjusted price of $21.70, representing a 96.84% decrease over that period. At the time, it had a market cap of $32.83 million and a volume of 63,020 shares. Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.44%1 Month Performance-33.82%3 Month Performance-37.73%Year-To-Date Performance-57.85%1 Year Performance-73.29%5 Year Performance-96.84% CANF Stock Chart for Tuesday, August, 12, 2025 CANF Chart by TradingView Can-Fite BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$0.69$0.70+1.44%$0.70$0.69248,829 shs$2.47 million08/08/2025$0.70$0.69-1.14%$0.70$0.6865,358 shs$2.43 million08/07/2025$0.69$0.70+1.40%$0.70$0.69120,244 shs$2.46 million08/06/2025$0.69$0.69-0.88%$0.70$0.68157,555 shs$2.43 million08/05/2025$0.67$0.69+2.52%$0.70$0.67126,693 shs$2.45 million08/04/2025$0.66$0.67+2.74%$0.69$0.6783,287 shs$2.39 million08/01/2025$0.67$0.66-2.00%$0.67$0.63244,627 shs$2.32 million07/31/2025$0.68$0.67-0.90%$0.68$0.66117,069 shs$2.37 million07/30/2025$0.71$0.68-5.26%$0.71$0.66489,055 shs$2.39 million07/29/2025$0.70$0.71+1.73%$0.73$0.67496,174 shs$2.53 million Get the Latest News and Ratings for CANF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$0.98$0.70-28.43%$1.00$0.693.33 million shs$2.48 million07/25/2025$1.01$0.98-2.97%$1.01$0.97231,228 shs$3.47 million07/24/2025$1.04$1.01-2.42%$1.04$0.99520,693 shs$3.58 million07/23/2025$1.03$1.04+0.98%$1.05$1.03103,518 shs$3.66 million07/22/2025$1.04$1.03-0.97%$1.04$1.0251,517 shs$3.63 million07/21/2025$1.04$1.04$1.05$1.0244,419 shs$3.66 million07/18/2025$1.05$1.04-0.96%$1.05$1.0337,016 shs$3.66 million07/17/2025$1.05$1.05$1.05$1.04105,456 shs$3.70 million07/16/2025$1.05$1.05$1.05$1.0433,126 shs$3.70 million07/15/2025$1.03$1.05+1.06%$1.05$1.0364,790 shs$3.70 million07/14/2025$1.04$1.03-0.10%$1.04$1.0299,109 shs$3.66 million07/11/2025$1.04$1.04$1.05$1.0231,778 shs$3.66 million Related Companies Acurx Pharmaceuticals Stock Price Chart Dogwood Therapeutics Stock Price Chart X4 Pharmaceuticals Stock Price Chart Aprea Therapeutics Stock Price Chart Soligenix Stock Price Chart Sonnet BioTherapeutics Stock Price Chart Chromocell Therapeutics Stock Price Chart Addex Therapeutics Stock Price Chart Cellectar Biosciences Stock Price Chart Cyclerion Therapeutics Stock Price Chart Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CANF) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access